Oct 22, 2018
Phase 1b/2 Data of Durvalumab Plus Danvatirsen Presented at European Society for Medical Oncology
Oct 10, 2018
Ionis Enters New Collaboration with Partner to Develop IONIS-FB-L Rx for Complement-Mediated Diseases
Aug 29, 2018
Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Aug 07, 2018
Ionis Reports Second Quarter 2018 Financial Results
Aug 02, 2018
IONIS-HTT Rx (RG6042) Granted PRIME Designation by the European Medicines Agency for the Treatment of People with Huntington's Disease
Aug 02, 2018
Akcea Therapeutics and PTC Therapeutics Collaborate to Commercialize Two Rare Disease Drugs in Latin America
Jul 24, 2018
Ionis Pharmaceuticals to Hold Second Quarter 2018 Financial Results Webcast
Jun 18, 2018
Ionis Pharmaceuticals Appoints Damien McDevitt as Chief Business Officer
Jun 05, 2018
Ionis Closes Strategic Collaboration with Biogen to Develop Drugs for a Broad Range of Neurological Diseases
May 23, 2018
Webcast Alert: Ionis Pharmaceuticals Provides Corporate Update at 2018 Annual Meeting of Stockholders
May 04, 2018
Ionis Reports First Quarter 2018 Financial Results
Apr 24, 2018
Ionis Pharmaceuticals to Hold First Quarter 2018 Financial Results Webcast
Apr 24, 2018
New Data from IONIS-HTT Rx Phase 1/2 Study Demonstrates Correlation Between Reduction of Disease-causing Protein and Improvement in Clinical Measures of Huntington's Disease
Apr 09, 2018
Ionis and AstraZeneca Advance New Drug for NASH
Mar 26, 2018
Ionis and Akcea Present New Data from ATTR Amyloidosis Program at 16th International Symposium on Amyloidosis
Mar 15, 2018
Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Mar 06, 2018
Ionis Pharmaceuticals to Present at Upcoming Investor Conferences
Mar 01, 2018
IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington's Disease
Feb 27, 2018
Ionis Reports Fourth Quarter and Full Year 2017 Financial Results
Feb 13, 2018
Ionis Pharmaceuticals to Hold 2017 Financial Results Conference Call